USE OF ANTI-HYPERGLYCEMIC MEDICATIONS IN PATIENTS WITH INCIDENT CKD AND T2D BY CKD SEVERITY: A DESCRIPTIVE STUDY USING A LARGE US ELECTRONIC HEALTH RECORDS DATABASE
Back
Abstract Number
WCN23-0277
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
USE OF ANTI-HYPERGLYCEMIC MEDICATIONS IN PATIENTS WITH INCIDENT CKD AND T2D BY CKD SEVERITY: A DESCRIPTIVE STUDY USING A LARGE US ELECTRONIC HEALTH RECORDS DATABASE
Co-authors
Vizcaya, D.(1)*;James, G.(2);Betts, K.(3);Wu, A.(3);Chen , J.(3);Elena, P.(4);Palombo, G.(2);Kubin, M.(5);Van Bommel-Wegmann, S.(5);Beeman, S.(6);Oberprieler, N.(7);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Bayer, Pharmaceuticals, Sant Joan Despi, Spain;(2)Bayer, Pharmaceuticals, Reading, United Kingdom;(3)Analysis Group, Data Science, Los Angeles, United States;(4)Bayer, Pharmaceuticals, Milano, Italy;(5)Bayer, Pharmaceuticals, Wuppertal, Germany;(6)Bayer, Pharmaceuticals, Whipanny, United States;(7)Bayer, Pharmaceuticals, Oslo, Norway;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/f3a50933a109d97be0115f931fc32802.pdf
Audio File
if any